Atom Therapeutics Co., Ltd

This study tests an experimental drug called ABP-745 in 200 adults with atherosclerosis (hardening of the arteries from plaque buildup). The goal is to see if it can reduce plaque in the arteries better than a placebo over 52 weeks. Participants must already be on cholesterol-low…

This study tests a new medicine, ABP-745, to see if it reduces pain and swelling from an acute gout flare better than the standard drug colchicine or a placebo. About 380 adults aged 18-70 with frequent gout flares will take one of the three treatments and report their pain level…

This study looks at how a new drug, ABP-671, interacts with the standard gout medication allopurinol. About 20 adults with gout who are already taking allopurinol will receive ABP-671 as well. Researchers will measure drug levels in the blood to see if there are any interactions,…